Truway Health is the lead sponsor of 16 current clinical trials in our USA register. None of its ClinicalTrials.gov trials is recruiting at the moment. The most common phase is Observational. The drugs named most often in its trials are Naltrexone. The most-studied condition is Biomarkers.
| Study | Phase | Status | Start | Registers |
|---|---|---|---|---|
|
Intracardiac Echocardiography Catheter Supply-Chain Reliability and Clinical Access Study
NCT07788040 · ClinicalTrials.gov ↗ · Cardiovascular Diseases, Arrhythmias, Cardiac, Atrial Fibrillation
|
Observational | Not yet open | 2026-09 | USA |
|
A Multiphase Operational and Environmental Assessment of Lunar Surface Habitation, Lunar Gateway Transit Systems, and Acceleration Pathways for Sustained Human Habitation of the Martian Surface
NCT07546461 · Extraterrestrial Habitation Systems, Lunar Surface Habitation, Lunar Water-Ice Resource Assessment
|
Observational | By invitation | 2026-06 | USA |
|
NeuroFinance Human Stress Trial During Financial and Informational Volatility
NCT07622589 · Psychological Stress, Anxiety, Emotional Stress
|
Observational | By invitation | 2026-07 | USA |
|
Truway Diagnostic Tools in Primary Care
NCT07209527 · Chronic Disease, Type 2 Diabetes Mellitus (T2DM), Obesity, Overweight, Hypertension
|
Phase EARLY_PHASE1 | By invitation | 2025-10 | USA |
|
Federated Learning for Point-of-Care Cardiac Ultrasound
NCT07800962 · Ventricular Dysfunction, Left, Ventricular Function, Left, Echocardiography
|
Observational | By invitation | 2026-08 | USA |
|
TruVascular Access - Ultrasound-Guided Vascular Access Study
NCT07798427 · Peripheral Venous Catheterization, Difficult Intravenous Access, Catheterization, Peripheral
|
Not applicable | By invitation | 2026-09 | USA |
|
Regenerative Medicine and Stem Cell-Based Interventions for Inner Ear Trauma, Tinnitus, and Sensorineural Hearing Loss
NCT07472023 · ClinicalTrials.gov ↗ · Sensorineural Hearing Loss, Tinnitus, Acoustic Trauma
|
Phase EARLY_PHASE1 | By invitation | 2026-03 | USA |
|
Evaluation of In-Vitro Cryo Therapeutic Protocols on Human Cell Samples (TWH-CRYO-001)
NCT07321028 · ClinicalTrials.gov ↗ · Cellular Injury and Post-Cryogenic Recovery, Cryogenic Cellular Stress, Cold-Induced Cellular Injury
|
Phase EARLY_PHASE1 | By invitation | 2025-12 | USA |
|
Multimodal Digital Biomarker Prediction of Acute Clinical Deterioration
NCT07817550 · ClinicalTrials.gov ↗ · Acute Disease, Disease Progression, Critical Illness
|
Observational | By invitation | 2026-09 | USA |
|
Mobile Behavioral Activation Program With Wearable Sensors and Secure Activity Verification
NCT07382804 · ClinicalTrials.gov ↗ · Health Behavior, Behavioral Activation, Sedentary Behavior
|
Not applicable | By invitation | 2026-01 | USA |
|
Deployment and Evaluation of Humanoid Robotics in Coalition-Aligned Clinical Care Settings
NCT07214896 · ClinicalTrials.gov ↗ · Mobility Impairment, Clinical Workflow Optimization, Sanitation Protocol Compliance
|
Phase 2 | By invitation | 2025-10 | USA |
|
Electromagnetic Immunotherapy Mapping and Cytokine Forecasting Study (QSIT)
NCT07221565 · ClinicalTrials.gov ↗ · Systemic Lupus Erythematosus, Rheumatoid Arthritis, Multiple Sclerosis
Drug: Naltrexone |
Phase 1/2 | By invitation | 2025-10 | USA |
|
Truway Whole-Body Digital Twin and Physiologic Resilience Study (TRU-OMNIBODY)
NCT07805044 · ClinicalTrials.gov ↗ · PHYSIOLOGICAL PHENOMENA, Homeostasis, Physical Functional Performance
|
Observational | By invitation | 2026-08 | USA |
|
Healthcare Integrity & Anti-Fraud Enforcement
NCT07217730 · ClinicalTrials.gov ↗ · Healthcare Fraud Schemes, Kickback Networks, Supply Chain Vulnerabilities
|
Observational | By invitation | 2025-10 | USA |
|
Clinical Time and Temporal Dynamics Study (CLIN-TIME)
NCT07812831 · ClinicalTrials.gov ↗ · Longitudinal Studies, Prospective Studies, Biomarkers
|
Observational | By invitation | 2026-09 | USA |
|
Multimodal Physiologic State Intelligence Study
NCT07814118 · ClinicalTrials.gov ↗ · Heart Failure, Cardiomyopathies, Pulmonary Hypertension
|
Observational | By invitation | 2026-09 | USA |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.
Drugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in USA | 16 | 0 |
A trial with sites in more than one country appears in each of those registers.
| Sponsor | Trials |
|---|---|
| Cuibai Wei，Clinical Professor | 2 |
| CareDx | 1 |
Sponsors with the most current trials registered for this condition.
Truway Health is the lead sponsor of 16 current trials on ClinicalTrials.gov in our USA register, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.
Not at the moment. None of its 16 ClinicalTrials.gov trials is recruiting; they are active but closed to enrolment, not yet open, or enrolling by invitation. Only the study team can confirm whether a patient is eligible.
Its current trials name 1 drug or biological as interventions. The most frequent are Naltrexone (1). The number in brackets is how many of its trials name each drug.
Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.
Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 26 Sep 2026.